First
First Tracks Biotherapeutics
Quick answer
First is a pharma company (TRAX) headquartered in SAN DIEGO, CA, USA with 24 tracked pipeline programs.
Pipeline (24)
2 cycles induction chemotherapy
Locally Advanced Nasopharyngeal Carcinoma
1 trials project20 mg sildenafil citrate by mouth
Pulmonary Hypertension
1 trials project3-N-butylphthalide
Multiple System Atrophy
1 trials project6-month course of antiandrogen drugs
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1 trials projectAZVUDINE
Chronic Hepatitis B
1 trials projectAcetazolamide Levamisole
HCC
1 trials projectAerobic Exercise
Primary Hypertension
1 trials projectAlirocumab
Intracranial Atherosclerosis
1 trials projectAmlodipine
Sleep Apnea Syndrome
1 trials projectAzacitidine Combined With Venetoclax and ATRA group
Acute Myeloid Leukemia
1 trials projectAzathioprine
Myasthenia Gravis
1 trials projectBedaquiline (B)
Pulmonary Tuberculosis
1 trials projectBotulinum Toxin type A (intradermal / submucosal injection at pain area)
Trigeminal Neuralgia
1 trials projectBusulfan (BU)
Primary Central Nervous System Lymphoma
1 trials projectCamrelizumab
Esophageal Cancer
2 trials projectCapecitabine monotherapy
Gastric Cancer
1 trials projectCapecitabine(Aibin)
Stage III Esophageal Squamous Cell Carcinoma
1 trials projectChemotherapy
Endometrial Cancer
1 trials projectChemotherapy
Acute Lymphoblastic Leukemia
1 trials projectClamp-Crushing technique
Hepatobiliary Disease
1 trials projectContinuous Gastrocnemius plane block with ropivacaine
Foot Ankle Injuries
1 trials projectCrystalline cellulose simple occlusive dressing
Split-thickness Skin Graft Donor Sites
1 trials projectCytarabine
Leukemia
1 trials projectDecitabine
Acute Myeloid Leukemia
1 trialsPatents (8)
US 12357666
Traditional Chinese herbal plant composition for improving symptoms of liver can
patentUS 12228572
Enhanced expression of polo-like kinase 3 (PLK3) in human immunodeficiency virus
patentUS 12220446
Use of upstream open reading frame 45aa-uORF nucleotide sequence of PTEN gene an
patentUS 12090156
Application of CB-839 in preparation of drug for inhibiting corneal neovasculari
patentUS 12076443
Preparation method of nanozyme composite-based hybrid hydrogel eye drop
patentUS 12016950
Devices and methods for treating ear pain
patentUS 11992555
Solid solution compositions and use in chronic inflammation
patentUS 11980602
Cannabinoid prodrug compounds